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Specific regions within the embryonic midbrain and cerebellum require different levels of
FGF signaling during development
M. Albert Basson, Diego Echevarria, Christina Petersen Ahn, Anamaria Sudarov, Alexandra L. Joyner,
Ivor J. Mason, Salvador Martinez and Gail R. Martin
There was an error published in Development 135, 889-898.
The incorrect image (a duplicate of Fig. S2B) was shown in Fig. S2A in the supplementary material and has now been corrected. The
findings of this experiment remain unchanged.
The authors apologise to readers for this mistake.
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INTRODUCTION
Remarkable progress has been made in understanding how the
development of anatomically and functionally distinct subdivisions of
the vertebrate brain is controlled. Midbrain and cerebellum formation
has been particularly well studied (Raible and Brand, 2004; Zervas et
al., 2005). The midbrain develops from the mesencephalon (mes) (see
Fig. 1D). The dorsal mes gives rise to the tectum, which comprises the
superior colliculus (SC) anteriorly and inferior colliculus (IC)
posteriorly, where visual and auditory stimuli are processed,
respectively. The cerebellum develops from dorsal rhombomere 1
(r1): the anterior-most segment of the hindbrain (see Fig. 1D). In
mouse, the cerebellum consists of a medial vermis, flanked laterally
by a pair of hemispheres (see Fig. 1E). The cerebellum, where motor
activity is coordinated, undergoes dramatic changes after birth that
transform it into a highly foliated structure (Sillitoe and Joyner, 2007).
The molecular mechanisms that subdivide the tectum and cerebellum
into subregions are poorly understood.
At early stages, signals that pattern both mes and r1 are produced
by a signaling center, the isthmic organizer (IsO), at the mes/r1
boundary (Echevarria et al., 2003; Nakamura et al., 2005; Partanen,
2007), thereby ensuring coordination of midbrain and cerebellum
development. One key component of the IsO signal is FGF8
(Crossley et al., 1996), a member of the fibroblast growth factor
(FGF) family (Itoh and Ornitz, 2004). In mouse, Fgf8 is expressed
in r1 from early neural plate [embryonic day (E) 8.25] through mid-
gestation (E12.5) stages. By E10.0, Fgf8 expression is localized in
r1, just posterior to the mes/r1 boundary, in a circular domain that is
interrupted by Fgf8-negative regions at the dorsal and ventral
midlines (roof and floor plates, respectively) (Crossley and Martin,
1995). When Fgf8 is inactivated in the early neural plate, all mes and
r1 cells die between E8.5 and E10. However, when Fgf8 expression
is only moderately reduced, the anterior midbrain appears normal,
but posterior midbrain, isthmus and vermis are lost (Chi et al., 2003).
The reason for such tissue loss in Fgf8 hypomorphs is unknown.
FGF8 regulates the expression of Fgf17 (Chi et al., 2003), which
is detected in a broad domain encompassing both prospective
posterior midbrain and cerebellum (Xu et al., 2000). In Fgf17-null
mice, part of the IC and anterior vermis are absent, but the remaining
midbrain and cerebellum appear normal. The extent of vermis loss
is increased in these mutants by removing one copy of Fgf8,
suggesting that the two FGF family members cooperate to control
cerebellum development (Xu et al., 2000).
The level of FGF signaling can affect cell fate during mes/r1
development. Ectopic expression of an Fgf8 splice variant, Fgf8b,
which encodes an FGF8 isoform with high affinity for FGF
receptors (Olsen et al., 2006), transforms mouse mes cells to a
cerebellar fate (Liu et al., 1999). By contrast, ectopic expression of
Fgf8a, which encodes an FGF8 isoform with much lower affinity
for FGF receptors (Olsen et al., 2006; Zhang et al., 2006), expands
the mes and transforms posterior forebrain (diencephalon)
progenitors to a midbrain fate (Lee et al., 1997; Liu et al., 1999).
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Importantly, when Fgf8b is ectopically expressed at low rather than
high level in chicken embryos, the results are similar to those
obtained with Fgf8a or Fgf17. Together, these data indicate that
specification of midbrain and cerebellum require different levels of
FGF signaling (Sato et al., 2001; Liu et al., 2003), and highlight the
importance of controlling FGF signaling during mes/r1
development.
Such control can be achieved intracellularly by sprouty proteins
(Hacohen et al., 1998; Casci et al., 1999), the expression of which is
induced by signaling through FGF receptors (FGFRs) and other
receptor tyrosine kinases (RTKs) (Mason et al., 2006). There are
four sprouty genes in mouse and human. Spry1 and Spry2 are
strongly expressed in mes/r1 from early neural plate stages, in cells
near the IsO (Minowada et al., 1999). In zebrafish (Furthauer et al.,
2001) and chicken (Suzuki-Hirano et al., 2005) embryos, increasing
sprouty gene expression above normal levels can antagonize FGF
activity and interfere with mes/r1 development.
Recent studies have demonstrated that the roof plate in r1 is
another important source of signals, including BMP ligands, for
cerebellar development (Chizhikov et al., 2006; Machold et al.,
2007). Roof plate development itself is controlled by Lmx1a
(Millonig et al., 2000), a gene positively regulated by BMP
signaling (Chizhikov and Millen, 2004a; Chizhikov et al., 2006).
It is not known whether signals emanating from the IsO affect
the development or function of the cerebellar roof plate or vice
versa.
Here, we have employed a mouse line carrying a conditional
Spry2 gain-of-function transgene in conjunction with an Fgf8null
allele to produce the equivalent of an FGF loss-of-function allelic
series specifically in mes/r1. By studying the phenotypic effects of
these genetic manipulations, we have uncovered potential
mechanism(s) by which FGF signaling differentially regulates the
development of specific regions within the midbrain and
cerebellum.
RESEARCH ARTICLE Development 135 (5)
Fig. 1. Spry2-GOF, a conditional Spry2 gain-of-function allele, and its expression following recombination by En1Cre. (A) Schematic
diagram illustrating the Spry2-GOF transgene. The CAGG promoter drives expression of the -Geo gene, which is followed by a triple
polyadenylation sequence (3 pA). Cre-mediated recombination deletes -Geo, and mouse Spry2 and human placental alkaline phosphatase
(PLAP) cDNAs are expressed as a bicistronic mRNA containing an internal ribosome entry site (IRES) that directs translation of PLAP. (B) Assays in
whole mount for -Geo expression (-GAL activity) in embryos hemizygous for Spry2-GOF. (C-K) Analysis of expression of the recombined Spry2-
GOF transgene in En1Cre/+;Spry2-GOF (mes/r1-S2GOF) mutants. (C-E) Assays for PLAP activity in embryos and postnatal brain at the stages
indicated. Blue staining identifies cells in which recombination of the transgene occurred. The arrow in D indicates two ventrolateral stripes in the
spinal cord. (F-K) RNA in situ hybridization assays in whole mount at the stages indicated, using a mouse Spry2 probe. The broken white lines
outline the left side of mes/r1 in the control embryos, where the probe detects endogenous Spry2 expression. In mes/r1-S2GOF embryos, the Spry2
RNA detected represents the sum of expression from the endogenous Spry2 gene and the recombined transgene. Regions in which there is ectopic
Spry2 expression in mes and in r1 are indicated by broken red lines (I,K) and by a red arrow (K), respectively. AER, apical ectodermal ridge of the
limb bud; BA1, first branchial arch; CbV, cerebellar vermis; CbH, cerebellar hemispheres; Mb, midbrain; mes; mesencephalon; r1, rhombomere 1;
so, somites.
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MATERIALS AND METHODS
Genotyping
All mutant alleles were maintained on a mixed genetic background.
Genotypes were determined by PCR assays using embryonic yolk sac or tail
DNA as a template. The Spry2-GOF allele (Calmont et al., 2006), which was
produced essentially as described by Lu et al. (Lu et al., 2006), was detected
using primers that amplify human PLAP (ALPP). Spry2 gain-of-function
homozygotes were identified using a quantitative PCR assay for PLAP
sequences (primers and conditions available upon request). Other alleles
were detected as previously described: En1Cre and Fgf8null (Chi et al., 2003);
Fgf8neo (Sun et al., 1999); and Fgf17 (Xu et al., 2000).
Histological analysis and assays for cell death and gene
expression
Noon of the day when a vaginal plug was detected was considered E0.5.
Embryos were staged more precisely by counting somites posterior to the
forelimb bud and scoring the first one counted as somite 13. Histological
analysis of late gestation and postnatal brains, and immunolocalization in
brain tissue were performed as previously described (Chi et al., 2003).
Assays for cell death were performed in whole mount by staining with
LysoTrackerT (Molecular Probes L-7528), as previously described by
Grieshammer et al. (Grieshammer et al., 2005). We confirmed that
LysoTrackerT staining gave results on En1Cre/+;Fgf8flox/– (referred to here
as mes/r1-Fgf8-KO) embryos similar to those we previously obtained using
Nile Blue Sulfate staining and TUNEL assays to detect cell death (Chi et al.,
2003).
For gene expression analysis, embryos were collected in cold PBS, fixed
in 4% paraformaldehyde and stored in 70% ethanol at –20°C. Some embryos
were embedded in paraffin and sectioned at 7 m. Standard protocols were
employed for RNA in situ hybridization on sections and in whole mount, and
for assaying -GAL and PLAP activity in whole mount.
RESULTS
Cre-mediated recombination of a conditional
Spry2 gain-of-function transgene in midbrain and
cerebellum progenitors
To reduce FGF signaling in mes/r1, we employed a mouse line
carrying a conditional Spry2 gain-of-function allele, Spry2-GOF
(Calmont et al., 2006). In these mice, transgene-expressing cells
produce -GEO, a fusion protein with both neomycin-resistance and
-galactosidase (-gal) activities (Friedrich and Soriano, 1991) (Fig.
1A). -Gal assays demonstrated that Spry2-GOF is expressed in
most cells of the embryo from E7.5 to at least E11.5 (Fig. 1B, and
data not shown). Cells in which the transgene has undergone Cre-
mediated recombination express a bicistronic mRNA containing
both Spry2- and human placental alkaline phosphatase (PLAP)-
coding sequences (Fig. 1A). PLAP protein thus functions as a
convenient reporter for expression of the recombined transgene.
To obtain mice in which the transgene was recombined in mes/r1,
we crossed animals carrying Spry2-GOF and En1Cre, an En1 allele
with cre inserted in the first exon (Kimmel et al., 2000). In their
En1Cre/+;Spry2-GOF offspring, we detected PLAP activity only in the
domains in which En1Cre is known to function (Li et al., 2002; Chi et
al., 2003). Thus, in the developing brain, no PLAP activity was
detected prior to E8.25 (not shown), but strong PLAP activity was
observed throughout mes/r1 from E8.75 (Fig. 1C). Subsequently,
because the CAGG promoter remains active in most embryo and adult
cells, PLAP activity was detected throughout the mes and r1 at E10.75
(Fig. 1D), and the midbrain and cerebellum on postnatal day (P) 22
(Fig. 1E). In addition, by E10.75, PLAP activity was detected in the
first branchial arch (Fig. 1D), presumably in mes/r1-derived neural
crest cells that continue to express the recombined Spry2-GOF
transgene under the control of the CAGG promoter. PLAP activity
was also detected in other domains in which En1 is normally
expressed (Kimmel et al., 2000) (Fig. 1D). No PLAP activity was
detected in control littermates (wild type or mutants carrying only
En1Cre/+ or only Spry2-GOF; not shown). En1Cre/+;Spry2-GOF
mutants will hereafter be referred to as mes/r1-S2GOF embryos, to
indicate that the recombined transgene was expressed in mes/r1.
To assess Spry2 expression directly from the recombined transgene,
we performed a whole-mount RNA in situ hybridization analysis on
mes/r1-S2GOF mutants and control littermates. Consistent with
previous studies (Minowada et al., 1999), in control embryos we
detected Spry2 RNA at E8.75 in a domain encompassing most of
mes/r1 (Fig. 1F), which subsequently became progressively more
restricted, such that by E9.25 and at E10.75 it encompassed the
posterior mes and r1 but not the anterior mes (Fig. 1H,J). In mes/r1-
S2GOF mutants at these stages (Fig. 1C,D), the level of Spry2 RNA
appeared to be only slightly increased within the normal domains of
Spry2 expression (Fig. 1G,I,K). However, because transgene
expression persisted in regions where Spry2 expression is normally
downregulated, we detected ectopic Spry2 expression in anterior mes
and posterior r1 at later stages (E9.25 and E10.75; Fig. 1I,K). In situ
hybridization analysis on sections of mes/r1-S2GOF mutants at 42
somites demonstrated that Spry2 RNA was distributed uniformly
within the ectopic expression domain (not shown). Together, our data
suggest that in mes/r1-S2GOF embryos, the level of Spry2 RNA is
slightly elevated within its normal expression domain and is
ectopically expressed throughout the remainder of the developing
midbrain and cerebellum from at least E8.75.
Similar effects on midbrain and cerebellum are
obtained by expressing one copy of recombined
Spry2-GOF in mes/r1 or by reducing Fgf17 and
Fgf8 gene dose
Histological analysis of mes/r1-S2GOF mutants shortly before birth
revealed the effects of expressing the recombined transgene on
midbrain and cerebellum development. In midsagittal sections of
E17.5 mes/r1-S2GOF mutants (n=4), the dorsal midbrain appeared
normal at its anterior end, some tissue loss was observed at the
posterior end of the SC, and the IC was absent (Fig. 2A,B; data not
shown). Staining for calretinin confirmed the absence of the IC,
which is normally calretinin-negative (Fig. 2C,D). Posterior to the
midbrain, the dorsal isthmus was also absent (Fig. 2A-D). The
medial cerebellum (vermis) also appeared to have lost tissue, but
only at its anterior end (Fig. 2A,B, and data not shown). By contrast,
basal plate derivatives in the midbrain [oculomotor nucleus (nIII),
substantia nigra and ventral tegmental area (SN-VTA)], and the
isthmus [trochlear nucleus (nIV)], were present, as was the r1-
derived locus coeruleus, and all appeared normal (not shown).
Mes/r1-S2GOF mutants were viable, and lacked the IC and
isthmus postnatally (Fig. 2G,H), demonstrating that the apparent
tissue loss observed at E17.5 was not due to a developmental delay.
In wild-type mice, there are strain-specific variations in vermis
foliation pattern, such that some strains have three distinct lobules
(I, II and III) anterior to the lobule of culmen (IV-V), and other
strains have only two (indicated as I-II and III in Fig. 2G) (Inouye
and Oda, 1980). In postnatal mes/r1-S2GOF mutants (n=5), lobules
I-III were either reduced or absent, whereas the remaining lobules
appeared essentially normal (Fig. 2H; data not shown). Thus,
expressing a single copy of the recombined Spry2-GOF transgene
in mes/r1 from an early developmental stage resulted in absence of
the posterior dorsal midbrain (IC), isthmus and anterior vermis.
There were no obvious abnormalities in these animals in other
tissues that developed from cells in which the Spry2-GOF transgene
underwent Cre-mediated recombination.
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The phenotype of mes/r1-S2GOF mutants described above is
remarkably similar to, although slightly more severe than, that
observed in Fgf17-null homozygotes carrying one copy of an Fgf8
null allele (Fgf17–/–; Fgf8+/– animals) (Xu et al., 2000). At birth, the
IC, isthmus and anterior tissue in the developing cerebellum
appeared to be absent in such compound FGF mutant animals (Fig.
2E,F), and at 3-4 weeks after birth, only one major lobule was
present anterior to lobules IV-V (Fig. 2I). These results suggest that
expressing a single copy of the recombined Spry2-GOF allele results
in a reduction in FGF signaling during midbrain and cerebellar
development to approximately the same degree as in Fgf17–/–;
Fgf8+/– mutants.
Reducing Fgf8 gene dose in mes/r1-S2GOF
mutants or expressing two copies of the
recombined Spry2-GOF allele in mes/r1 results in
loss of the cerebellar vermis
If expression of the recombined Spry2-GOF allele in mes/r1 does
indeed function to reduce FGF signaling, one might expect that
reducing it even further, for example by reducing Fgf8 gene dose,
would result in a more severe phenotype. To test this prediction, we
examined En1Cre/+;Spry2-GOF;Fgf8+/– (mes/r1-S2GOF;F8)
mutants at E17.5. When viewed in whole mount, it was evident that
they lacked the entire vermis (Fig. 3A,B). Histological analysis
showed that only the anterior region of the dorsal midbrain,
including the anterior-most mes-derived structure, the PPT (Lagares
et al., 1994), appeared normal; tissue was missing at the posterior
end of the SC; and the IC, dorsal isthmus and vermis were absent
(Fig. 3C-E). Mes/r1-S2GOF;F8 mutants could be classified in two
groups: group I (n=3/5) had some tissue loss at the posterior end of
the SC, and basal structures including nIII, nIV and the SN-VTA
were present although somewhat reduced; group II (n=2/5) had
more tissue loss at the posterior end of the SC and the basal
structures were absent (Fig. 3C-K). Lateral r1-derived tissue was
present in both groups, as evidenced by the presence of the locus
coeruleus, but it was clearly reduced in group II (Fig. 3I-K).
We next examined animals carrying En1Cre/+ and two copies of
Spry2-GOF (mes/r1-S2GOF;S2GOF; n=3), which appeared similar
to mes/r1-S2GOF;F8 mutants in group I (not shown). Thus,
expressing a second copy of the recombined Spry2-GOF allele
appeared to inhibit FGF signaling to approximately the same extent
as removing one copy of the Fgf8 gene in mes/r1-S2GOF animals.
The phenotype of the group I mes/r1-S2GOF;F8 and mes/r1-
S2GOF;S2GOF mutants is similar to that observed in embryos
homozygous for Fgf8neo (Chi et al., 2003), a hypomorphic allele of
Fgf8, that has been estimated to express Fgf8 RNA at ~40% of the
level in wild-type embryos (Meyers et al., 1998). Unlike Fgf8neo/neo
animals, which have numerous developmental abnormalities caused
by reduced FGF8 signaling in all tissues and die at birth, several
mes/r1-S2GOF;F8 and mes/r1-S2GOF;S2GOF mutants survived
to adulthood. Thus, we were able to determine the postnatal
consequences of the midbrain and cerebellum defects that were
detected just before birth. In P21 mes/r1-S2GOF;F8 animals, a
complete loss of vermis was readily observed in intact brains, whereas
the cerebellar hemispheres were present, but appeared somewhat
reduced (Fig. 3L,M). Section analysis at P28 revealed a hemisphere-
like foliation pattern in lateral sections and further showed that the
granule cell layer was of normal thickness; staining with calbindin
demonstrated that the density of Purkinje cells was apparently normal,
as were their axon and dendrite projections (see Fig. S1 in the
supplementary material). Consistent with the absence of the vermis,
the Fastigial nucleus was absent, whereas the Dentate nucleus
appeared relatively unaffected (not shown). The lack of vermis, which
controls posture and locomotion, presumably explains our finding that
mes/r1-S2GOF;F8 mutants exhibited a widened gait and pronounced
ataxia that increased in severity with age (not shown).
Cell death occurs in the anterior mesencephalon
in Spry2-GOF mutants and Fgf8 hypomorphs
We have previously shown that eliminating Fgf8 function in mes/r1
causes extensive cell death between the 11 and 28 somite stages,
resulting in complete absence of the midbrain, isthmus and
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Fig. 2. Expression of a single copy of the
recombined Spry2-GOF allele in mes/r1 causes
absence of the inferior colliculus and anterior
vermis. (A,B,E-I) Midsagittal sections of brains of the
genotypes indicated, collected at the stages denoted
and stained with Cresyl Violet or Hematoxylin and
Eosin (I). Anterior is towards the left, posterior is
towards the right. In control embryos, the posterior
midbrain and anterior hindbrain regions that are
absent in the mutant embryos are demarcated by red
and yellow broken lines, respectively; in the mutant
embryos, the regions where the missing midbrain and
anterior hindbrain tissue would normally be found
are indicated by red and yellow asterisks, respectively.
(C,D) Higher power view of the tissue shown in A
and B, respectively, stained with an antibody against
calretinin (CR). The CR-negative inferior colliculus in
the control is indicated by a broken red line. In the
mutant, this CR-negative region, as well as the
isthmus and velum medullare are absent (arrowhead).
(G-I) Comparison of vermis development in control,
mes/r1-S2GOF, and Fgf17–/–; Fgf8+/– animals at
~3 weeks of age. CP, choroid plexus; IC, inferior
colliculus; SC, superior colliculus; VM, velum
medullare. The lobules of the vermis are indicated by
Roman numerals, as described by Inouye and Oda
(Inouye and Oda, 1980).
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cerebellum (Chi et al., 2003). However, the effects of only
moderately reducing the level of FGF gene expression on cell
survival in mes/r1 were not examined. We therefore sought to
determine whether abnormal cell death could account for the tissue
loss in embryos that were homozygous for Fgf8neo or that expressed
the recombined Spry2-GOF transgene, by staining with
LysotrackerT (see Materials and methods) at 4- to 6-hour intervals
between E8.75 and E10.75 (12 to 38 somites).
We detected a relatively small domain in Fgf8neo/neo and
mes/r1-S2GOF mutants in which cell death was more extensive
than in controls, but only at the 15- to 16-somite and 18- to 20-
somite stages, respectively. A similar domain of abnormal cell
death was observed at 18- to 20-somites in mes/r1-S2GOF;F8
mutants, in which the level of FGF signaling is lower than in
mes/r1-S2GOF mutants. Surprisingly, given that the anterior
midbrain appears to develop normally in all these mutants (Fig.
2A,B; Fig. 3C-E) (Chi et al., 2003), the domain of abnormal cell
death was localized at the anterior end of the dorsal mes (Fig. 4A-
E; data not shown). To confirm the location of this abnormal cell
death, we performed an in situ hybridization assay on the
LysotrackerT-labeled embryos using a probe for Pax6. This gene
is expressed throughout the prospective forebrain, with the
posterior limit of its expression domain defining the boundary
between the developing diencephalon (di) and mes. The domain
of abnormal cell death, as detected by LysotrackerT staining, was
indeed localized immediately posterior to the di/mes boundary
(Fig. 4C,C, and data not shown).
One explanation for the abnormal cell death in the mutants is that
a certain level of FGF signaling from the IsO is required for cell
survival, and that it falls below that level in the anterior mes when
either Spry2 is ectopically expressed or Fgf8 expression is reduced
(as in Fgf8neo/neo embryos). To investigate this hypothesis, we
determined the range of FGF signaling in mes/r1 by assaying for
Spry1 expression, which is induced by and thus serves as a reporter
for a high level of FGF signaling (Liu et al., 2003; Olsen et al.,
2006). We found that at the 18- to 20-somite stage, the distance from
the isthmic constriction to the anterior limit of the Spry1 expression
domain was reduced in mes/r1-S2GOF and mes/r1-S2GOF;F8
mutants compared with that in control embryos (Fig. 4F-H). These
data provide evidence that the range of FGF signaling from the IsO
is decreased in the mes of these mutants, supporting the hypothesis
that the observed anterior cell death is a consequence of reduced
FGF signaling.
Similar results were obtained in assays for En1, En2 and Efna2
expression (Fig. 4 and data not shown). At 33-35 somites, the Efna2
expression domain was smaller than normal in mes/r1-Spry2-GOF
and even smaller in mes/r1-Spry2-GOF;F8 embryos (Fig. 4I-K).
These data are consistent with studies showing that En1 and En2
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Fig. 3. Decreasing Fgf8 gene dose in mes/r1-
S2GOF embryos results in absence of the
vermis. (A,B) Dorsal views of brains collected
from E17.5 embryos of the genotypes indicated.
In the mutant brain, the region where the vermis
would normally be found is indicated by a yellow
asterisk. (C-E) Low-magnification views of
midsagittal sections of E17.5 control and mes/r1-
S2GOF;F8 mutants, stained with Cresyl Violet.
(D,E) Examples of the group I (milder) and group
II (more severe) brain phenotypes observed in the
mutants. The broken red and yellow lines and red
and yellow asterisks are explained in the legend
to Fig. 2A,B,E,F. The areas outlined in C-E are
shown at higher magnification in F-H,
respectively. (F-H) High magnification views of
basal structures. When present, nIII and nIV are
circled with broken lines. (I-K) High magnification
views of more lateral sagittal sections of the same
brains, assayed by immunohistochemistry with an
antibody against tyrosine hydroxylase, which
specifically stains nuclei in the lateral posterior
diencephalon, midbrain and anterior hindbrain.
The broken red line indicates the boundary
between diencephalon and midbrain.
(L,M) Dorsal views of intact brains collected from
P21 mice of the genotypes indicated, stained
with ink. The broken line in L outlines the vermis,
which is absent in the mutant brain. CbV,
cerebellar vermis; CbH, cerebellar hemispheres;
CP, choroid plexus; Di, diencephalon; IC, inferior
colliculus; Is, isthmus; LoC, locus ceruleus; mlf,
medial longitudinal fascicle; nIII, oculomotor
nucleus; nIV, trochlear nucleus; PPT, posterior
pretectal nucleus; SC, superior colliculus; SN-VTA,
substantia nigra-ventral tegmental area.
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expression is regulated by FGF signaling (Trokovic et al., 2003), and
that ephrin gene expression is controlled by engrailed genes
(Nakamura, 2001). In addition, as expected for mutants with reduced
FGF signaling from the IsO (Zervas et al., 2005; Partanen, 2007),
we found that the posterior limit of Otx2 expression was slightly less
sharp in mes/r1-S2GOF;F8 mutants than in controls, and a few
scattered Otx2-positive cells were detected in r1. Furthermore, Gbx2
and Wnt1 expression were significantly reduced in anterior r1 and
the posterior midbrain, respectively (see Fig. S2 in the
supplementary material).
The roof plate is expanded in anterior
rhombomere 1 in mes/r1-S2GOF;F8 mutants
Importantly, in the experiments described above we detected no
abnormal cell death in the prospective posterior midbrain or
cerebellum of mes/r1-S2GOF or mes/r1-S2GOF;F8 mutants (Fig. 4A-
C; data not shown), suggesting that the loss of IC, isthmus and vermis
in these mutants is not due to cell death between E8.75 and E11.5. An
alternative explanation for the loss of vermis in mes/r1-S2GOF;F8
mutants was suggested by an analysis of transverse sections through
anterior r1 at E11.5. In control embryos, the roof plate (dorsal midline)
was characteristically thin, i.e. only two or three cell layers deep,
across a mediolateral domain five to eight cell diameters in width (Fig.
5A,A). By contrast, in mes/r1-S2GOF;F8 mutants at a comparable
anteroposterior (AP) level, the roof plate was similarly thin but much
wider than normal (Fig. 5B,B). This region in the mutants appeared
similar in width to the roof plate in more posterior sections of control
and mutant embryos, where it comprised a single cell layer that was
~30 cell diameters wide (Fig. 5C-D).
We next examined gene expression patterns at earlier stages. In
control embryos at E10.5, as well as in mes/r1-S2GOF embryos, the
near circular Fgf8 expression domain in anterior r1 is interrupted at
the dorsal midline by a small group of Fgf8-negative roof plate cells
(Fig. 5E,F; data not shown). In mes/r1-S2GOF;F8 embryos, the
Fgf8 expression pattern appeared almost normal up to E9.5 (28
somites; Fig. 5H,I), but by E10.5 (34 somites) the Fgf8-negative
domain in dorsal r1 was much wider than normal (Fig. 5G, compare
with 5E,F). In contrast to Fgf8, Bmp7 expression is a positive marker
of the roof plate. In control and mes/r1-S2GOF embryos at E10.5, it
was detected in a narrow domain in anterior r1 that progressively
widened towards posterior r1 (Alder et al., 1999) (Fig. 5J,K).
However, in mes/r1-S2GOF;F8 embryos, a wider Bmp7-positive
roof plate domain was observed in anterior r1 (Fig. 5L, compare
with 5J,K).
Together, these data provide strong evidence that the roof plate
had expanded laterally in anterior r1 in mes/r1-S2GOF;F8 embryos.
Fate-mapping studies in the mouse embryo have localized vermis
progenitors to a small domain flanking the dorsal midline in the
anterior-most region of r1 at E12.5, and there is evidence that at
earlier stages these cells are likewise localized close to the dorsal
midline (Sgaier et al., 2005). Thus, it appears that the region
containing the vermis progenitors, which is normally positive for
Fgf8 and negative for Bmp7 expression, has been replaced by Fgf8-
negative Bmp7-positive roof plate cells in mes/r1-S2GOF;F8
embryos. These results indicate that reducing FGF signaling to the
level attained in mes/r1-S2GOF;F8 embryos causes an expansion of
the roof plate between the 28- and 34-somite stages, possibly at the
expense of vermis progenitors.
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Fig. 4. Reducing FGF signaling from the isthmic
organizer results in cell death in the anterior
mesencephalon. (A-E) Lateral views of embryos of the
genotypes indicated, collected at the somite stages
denoted and labeled with LysotrackerT (LysoT), which
marks regions in which dead cells are abundant. The
approximate position of the isthmic constriction (Is) is
indicated. (C) The embryo shown in C was fixed after
labeling with LysoT and assayed by RNA in situ
hybridization for Pax6 expression. The broken yellow
line indicates the posterior limit of Pax6 expression,
which lies at the border between the prospective
forebrain (diencephalon, Di) and midbrain
(mesencephalon, Mes). In control embryos (A,D), LysoT
labeling is detected where neural crest (NC) is migrating
into the first branchial arch (BA1), but there is relatively
little labeling in the neuroepithelium. By contrast, in the
mutant embryos (B,C,E) there is extensive LysoT labeling
in the mes (white arrows). (F-K) Embryos of the
genotypes indicated, collected at the somite stages
indicated, were assayed in whole mount by RNA in situ
hybridization using a probe for Spry1 or Efna2. The
extent of the expression domain from the mes/r1
boundary (red circle) towards the forebrain is indicated
by a broken red arrow.
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BMP target gene expression is increased and BMP
antagonist gene expression is decreased in
mes/r1-S2GOF;F8 mutants
Previous studies have indicated that roof plate cells express several
BMP family members in addition to Bmp7, and that BMP signaling
is necessary and sufficient for roof plate development in the chick
neural tube (Lee and Jessell, 1999; Chizhikov and Millen, 2004b;
Chizhikov and Millen, 2004c; Liu et al., 2004). The transcription
factor gene Msx1 is a downstream target of BMP signaling in the
dorsal neural tube, and misexpression of Msx1 in the chick spinal
cord results in expansion of the roof plate (Liu et al., 2004).
Therefore, to determine whether excess BMP signaling might be
responsible for the roof plate expansion we observed in mes/r1-
S2GOF;F8 embryos at E10.5, we assayed for Msx1 expression as a
readout for BMP signaling in dorsal r1. The domain of Msx1
expression was indeed significantly expanded mediolaterally in
anterior r1 in mes/r1-S2GOF;F8 embryos as compared with control
embryos at 33 somites (Fig. 5M,N). These data support the
hypothesis that a decrease in FGF signaling in r1 results in an
increase in BMP signaling and expansion of the roof plate.
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Fig. 5. The roof plate is expanded and Grem1 expression is reduced in mes/r1-S2GOF;F8 embryos. (A-D) Transverse sections through r1 of a
control and a mes/r1-S2GOF;F8 embryo at 48 somites (E11.75), stained with Hematoxylin and Eosin. Every third or fourth section in the series was
assayed by RNA in situ hybridization with a probe for Otx2, to locate the posterior limit of the mesencephalon (not shown). The broken lines in the inset
in A illustrate the approximate levels at which the anterior (A) and posterior (P) sections were cut, i.e. within 40-100 and 130-250 m of the posterior
limit of the Otx2 expression domain (indicated in blue), respectively. The sections in all panels are shown at the same magnification. The regions
demarcated by broken boxes in A-D are shown at fourfold higher magnification in A-D, respectively. The mediolateral width of the dorsal midline
domain in which the neuroepithelium is only two or three cell layers thick is indicated by red brackets (A-D). (E-L,O,P) RNA in situ hybridization assays in
whole mount using the probes indicated. Dorsal views of embryos of the genotypes indicated, collected at the stages denoted. Anterior is towards the
top, posterior towards the bottom. (E-I) The roof plate that bisects the Fgf8 expression domain is indicated by arrowheads. In control and mes/r1-S2GOF
embryos, the Fgf8-negative roof plate is difficult to discern; it is considerably expanded mediolaterally in the mes/r1-S2GOF;F8 embryo (open arrowhead
in G). The lateral and ventral aspect of the Fgf8 expression domain in r1 is visible in E and G on the left side, through the roof plate. (J-L) A broken red
line is drawn at the same distance posterior to the isthmic constriction at the mes/r1 boundary (black arrow). Bmp7 expression marks the roof plate, and
the roof plate widens closer to the isthmic constriction in the mes/r1-S2GOF;F8 embryo than in the control and mes/r1-S2GOF embryos.
(M,N) Transverse sections through anterior r1 at approximately the same AP level as in A and B, hybridized with a probe for Msx1. The mediolateral
extent of the Msx1 expression domain from the center of the roof plate (open circle) is indicated by a broken red arrow. (O,P) Grem1 expression is readily
detected at the dorsal midline of r1 in the control embryo, but is barely detected in r1 of the mes/r1-S2GOF;F8 embryo (red asterisk).
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In considering how FGF signaling in anterior r1 could function to
inhibit BMP signaling, we investigated the possibility that it might
induce or maintain the expression of genes that encode secreted
BMP antagonists. One such gene is gremlin 1 (Grem1) (Hsu et al.,
1998), which is expressed in the roof plate of anterior r1 (Pearce et
al., 1999; Louvi et al., 2003). We found that in control embryos at
E9.25 (22 somites), Grem1 RNA was readily detected in the roof
plate and adjacent neuroepithelium (Fig. 5O, and data not shown),
whereas in mes/r1-S2GOF;F8 embryos Grem1 expression was
barely detected in anterior r1 (Fig. 5P). By contrast, Grem1
expression was only moderately reduced in mes/r1-S2GOF embryos
(not shown). These results suggest that a normal function of FGF
signaling from the IsO is to inhibit BMP signaling in dorsal r1 via a
positive effect on Grem1 expression.
DISCUSSION
In this study, we produced the equivalent of an FGF loss-of-
function allelic series specifically in mes/r1 and examined the
effects of progressively reducing FGF signaling on midbrain and
cerebellum development. By recombining one copy of a
conditional Spry2 gain-of-function allele throughout mes/r1 at
~E8.5, we obtained mes/r1-S2GOF mutants with a phenotype
similar to that of Fgf17–/–;Fgf8+/– mutants (Xu et al., 2000). When
we reduced Fgf8 gene dose in mes/r1-S2GOF mutants, or
produced animals with two copies of the recombined Spry2-GOF
allele, we obtained a more severe phenotype, which resembled
that of embryos homozygous for an Fgf8 hypomorphic allele
(Fgf8neo) (Chi et al., 2003). Together, these data strongly support
the hypothesis that expression of the recombined Spry2-GOF
allele results in an inhibition of signaling via FGF receptors rather
than other RTKs during midbrain and cerebellum development. A
dorsal mes/r1 phenotype similar to that in mes/r1-S2GOF;F8
embryos has also been observed following conditional
inactivation of Fgfr1 in mes/r1 (Trokovic et al., 2003), suggesting
that the FGF signaling that is affected in the Spry2 gain-of-
function mutants is primarily relayed by FGFR1.
The results of our analysis provide genetic evidence consistent
with the proposal that the processes that shape the midbrain and
cerebellum require distinct levels of FGF signaling (Liu et al., 1999;
Sato et al., 2001; Liu et al., 2003), and further reveal that
anatomically and functionally distinct regions within the midbrain
and cerebellum require different levels of FGF signaling for their
development. This conclusion is consistent with the results of a
recent analysis showing that when En1/En2 function, which is
apparently downstream of FGF signaling from the IsO, is
progressively compromised, specific functional domains of the
tectum and vermis are lost in a dose-dependent manner (Sgaier et
al., 2007). In addition, we present evidence that FGF signaling
influences the balance between vermis and roof-plate development
in anterior r1 via an effect on BMP signaling.
The effects of Spry2 gain-of-function in mes/r1
differ in mouse and chicken embryos
The phenotypes we observed in our mutant mice differ from those
reported in chicken embryos, in which ectopic expression of Spry2
caused cells in r1 to express Otx2, a marker for the mes, and to
develop into midbrain tissue (Suzuki-Hirano et al., 2005). We did
observe that Otx2 expression was abnormal in mes/r1-S2GOF;F8
embryos, in that the boundary between Otx2-positive and Otx2-
negative cells was not as sharp as in control embryos and there
were a few Otx2-positive cells scattered in r1 (see Fig. S2 in the
supplementary material). However, we found no evidence that r1
cells took on a midbrain fate. Instead, misexpressing Spry2 in
mes/r1 resulted in defects in vermis development. Although there
is evidence that the forced expression of Otx2 in r1 from E8.75 can
transform anterior r1 into midbrain tissue in the mouse embryo
(Broccoli et al., 1999), there is as yet no direct evidence that mouse
r1 can give rise to midbrain tissue when FGF signaling is reduced.
The disparity between our findings and those of Suzuki-Hirano et
al. (Suzuki-Hirano et al., 2005) might be due to differences in the
methods employed to obtain ectopic sprouty gene expression, i.e.
sustained expression of an inherited transgene in the mouse versus
transient expression of a transgene introduced by electroporation
in the chicken embryo. Alternatively, it is possible that the
different results reflect differences in the mechanisms that control
the level of FGF signaling in mouse versus chicken brain
development.
Loss of the posterior tectum caused by reducing
FGF signaling can be explained by death of
anterior cells and mis-specification of posterior
cells as anterior tectum
A specific loss of the IC, with normal development of the SC, is a
feature common to mutants in which FGF signaling is moderately
reduced in mes/r1, including Fgf17–/–;Fgf8+/– embryos (Xu et al.,
2000), Fgf8neo/neo embryos (Chi et al., 2003) and embryos in which
Fgfr1 has been inactivated in mes/r1 (Trokovic et al., 2003), but the
mechanism by which this loss occurs is not known. Death of IC
progenitors is one possible explanation, as we previously showed
that inactivation of Fgf8 in mes/r1 by the 10-somite stage results in
apoptosis throughout the mes (Chi et al., 2003). However, cell death
was not detected at E9.5 in the mesencephalon when Fgfr1 was
inactivated (Trokovic et al., 2003).
Here, we show that a moderate reduction in FGF signaling does
cause abnormal cell death prior to E9.25, but that the dying cells are
detected only in the anterior mes. To explain this localization, we
propose that there is a minimum level of FGF signaling below which
cells in the mes die. In normal embryos, there is sufficient FGF
signaling to sustain survival, even of cells that are furthest from the
source of FGFs in the IsO (Fig. 6A). However, when FGF signaling
is moderately reduced, as for example in mes/r1-S2GOF mutants,
only cells close to the IsO attain the level of FGF signaling required
for survival. At early stages, when the mes is relatively small, all the
cells are sufficiently close to the IsO. But as the mes increases in size
and the anterior-most cells in such mutants are displaced progressively
further from the IsO, they reach a point at which they are too far from
the IsO to attain the level of FGF signaling required for survival, and
therefore they die.
The observation that cell death is restricted to the anterior mes
suggests the following explanation for the loss of the IC in mutants
with reduced FGF signaling in the mes: AP cell fates have not yet
been determined in the mes at the stage when the cells are dying, and
the remaining posterior cells are subsequently specified as SC
because of the low level of FGF signaling. Consistent with this
hypothesis, it has been shown that fate changes can occur in explants
of E9.5 mouse midbrains (Liu et al., 1999). Presumably, if cells in
the anterior mes had died at a stage after the fate of all mes cells had
been determined, a normal SC would not have formed. This model
further suggests that specification of IC progenitors requires a higher
level of FGF signaling than specification of SC progenitors. This
idea is supported by data showing that increasing FGF signaling, by
inserting beads loaded with FGF protein in the anterior mes of
chicken embryos, induces anterior cells to take on a posterior fate
(Martinez et al., 1999; Shamim et al., 1999).
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Loss of the vermis caused by reducing FGF
signaling can be explained by an increase in BMP
signaling and expansion of the roofplate
A loss of the entire vermis is observed when FGF signaling is reduced
to a level lower than in Fgf17–/–;Fgf8+/– and mes/r1-S2GOF mutants.
Our data indicate that abnormal cell death is not responsible for the
loss of the vermis in such mutant embryos. Instead, the vermis may
be absent because a specific minimum level of FGF signaling is
required for specification and/or expansion of vermis progenitors (Liu
et al., 2003), and that level is not attained in such mutants. Another
possibility is based on our observation that the roof plate in r1 is
abnormally expanded in mes/r1-S2GOF;F8 embryos. Although this
abnormality might be secondary to a failure of vermis development,
we favor the hypothesis that the converse is true, and that the observed
expansion of the roof plate is the primary cause of loss of the vermis
(Fig. 6B).
The model we advocate is based on studies showing that in the
spinal cord, the roof plate forms in response to BMP signaling from the
adjacent epidermal ectoderm (Lee and Jessell, 1999; Chizhikov and
Millen, 2004c; Chizhikov and Millen, 2005), that overexpression of
Lmx1a in mouse r1 is associated with increased BMP signaling and
increased roof plate formation (Chizhikov et al., 2006), and that BMP
signaling can be inhibited by FGF signaling in numerous
developmental settings, including the forebrain (Storm et al., 2003) and
midbrain (Alexandre et al., 2006). We propose that in r1, roof plate
formation is likewise controlled by BMP signaling from the ectoderm,
which in turn is inhibited by FGF signaling from the IsO. This
inhibitory interaction could explain why the roof plate is normally so
narrow in anterior r1, adjacent to the IsO where FGF ligands are
produced, but is much wider in more posterior r1. Accordingly, when
FGF signaling is sufficiently reduced, as in mes/r1-S2GOF;F8
embryos, BMP signaling increases, and the roof plate in anterior r1
becomes abnormally wide (Fig. 6C). In support of this idea, we found
that in mes/r1-S2GOF;F8 embryos, BMP signaling is increased, as
evidenced by an expansion of the Msx1 expression domain. Moreover,
we observed that a dramatic reduction in expression of the BMP
antagonist Grem1 precedes abnormal expansion of the roof plate by
~12 hours, suggesting a molecular mechanism by which FGF signaling
could exert a negative effect on BMP signaling. However, GREM1
alone is unlikely to be the sole factor responsible for mediating the
proposed inhibitory effect of FGF signaling on BMP signaling and roof
plate expansion in r1, because we found that roof plate development
appears normal in Grem1-null embryos (not shown).
An important question is how might the expansion of the roof plate
observed in mes/r1-S2GOF;F8 mutants compromise vermis
development? One possibility is based on the fact that the roof plate
itself expresses BMPs (Alder et al., 1999; Lee and Jessell, 1999;
Alexandre et al., 2006), and an increase in the size of the cell
population producing these potent signaling molecules might in turn
cause the nearby vermis progenitors to slow their proliferation or
differentiate prematurely, leading ultimately to absence of the vermis
(Alder et al., 1999; Krizhanovsky and Ben-Arie, 2006; Machold et al.,
2007). Alternatively, as misexpression of the BMP effector MSX1
results in the conversion of spinal cord neuroepithelum into roof plate
(Liu et al., 2004), it is possible that the increase in Msx1 expression in
mes/r1-S2GOF;F8 mutants functions to stimulate roof plate
development at the expense of the vermis by converting vermis
progenitors to a roof plate fate. Further studies will be needed to
distinguish between these possibilities.
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Fig. 6. A model to explain the phenotypes obtained when FGF
signaling is progressively reduced in mes/r1. Schematic diagrams
illustrate dorsal views of mes/r1 in embryos of the genotypes indicated
at the somite stages denoted. The intensity of the blue color in the
triangle to the left of a diagram illustrates the level of FGF signaling.
(A) The regions in which cells are dying or have already died are
indicated by red stippling. (B) The regions that contain the progenitors
(p) of the superior colliculus (SC), inferior colliculus (IC), cerebellar vermis
(CbV) and cerebellar hemispheres (CbH) are indicated. The phenotypes
observed in mutants that attain progressively lower levels of FGF
signaling are illustrated. In mes/r1-S2GOF embryos, the anterior mes has
been lost, and the surviving posterior cells are specified to an anterior
(SC) fate. Consequently the IC does not develop. In mes/r1-S2GOF;F8
embryos, the effects on the mes are similar and, in addition, the vermis
fails to develop because roof plate (RP) expansion in r1 results in a loss of
CbV progenitors. (C) In the wild-type embryo, FGF signaling
induces/maintains the expression of Grem1, which functions to inhibit
BMP signaling and expression of the BMP effector MSX1. This pathway
maintains the normal balance of vermis and roof plate development. In
the mes/r1-S2GOF;F8 embryo, the reduction in the level of FGF signaling
results in a severe reduction in Grem1 expression. In the absence of this
antagonist, the level of BMP signaling and therefore MSX1 expression
increases and an expanded roof plate develops where the vermis
progenitors normally reside. D
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